Non-Hodgkin lymphoma (NHL) is cancer that begins in lymphocytes, white blood cells that are an important part of the body’s infection-fighting immune system. It is one of the most common cancers in the United States, with an estimated 70,000 new cases diagnosed each year. The other main type of lymphoma, Hodgkin’s lymphoma, is much less common. The outlook for people with NHL depends on the type, the stage, and the treatment they receive.
Better Survival Rates for Lymphoma
Studies have shown that the first treatment you receive for cancer is by far the most important. On average, lymphoma patients who begin their treatment through Seattle Cancer Care Alliance (SCCA) have better survival rates than those who started treatment elsewhere.
Axi-cel (YESCARTA™) – New FDA-approved CAR T-cell therapy
SCCA is one of the first cancer centers in the nation, and the only center in the Northwest, to offer axicabtagene ciloleucel (axi-cel), also known by the brand name YESCARTA™. This new immunotherapy uses engineered cell therapy to harnesses the power of a patient’s own immune system to treat adults with aggressive NHL.
Precision Medicine, Including Clinical Studies
As a patient of SCCA, you receive expertly targeted and delivered care, tailored to your specific type, subtype, and stage of lymphoma. Through SCCA, you have access to the full spectrum of lymphoma treatments, including advanced therapies being explored in several dozen ongoing clinical studies for lymphoma conducted through SCCA and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
Greatest Experience with Bone Marrow Transplants
For people with lymphoma who are good candidates for stem cell transplants, the Fred Hutchinson Transplant program at SCCA is the most experienced transplant program in the world. It ranked first in outcomes in a multi-year study by the National Marrow Donor Program that measured one-year survival rates of patients at 122 transplant centers nationwide.
Doctors with Leading-Edge Expertise
SCCA patients diagnosed with non-Hodgkin’s lymphoma receive state-of-the-art care from a team of specialists, including:
- Medical oncologists who specialize in targeted therapies and advanced chemotherapy treatments
- Hematopathologists expert in identifying lymphomas in biopsied tissue
- Radiation oncologists who have special expertise in targeted radiation therapy
- Experienced transplant specialists at the center that pioneered bone marrow transplantation as a treatment for blood diseases more than 40 years ago